Women's Health
Reducing heart risks in the wake of breast cancer treatment
Hormone therapies may increase cardiovascular risks, but making lifestyle changes and being aware of risk factors can help protect you.
Today, the vast majority of women diagnosed with breast cancer survive the disease—91% are still alive five years after their diagnosis. One reason for this is the use of hormone therapies. These drugs can treat — or prevent a recurrence of — estrogen-fueled tumors, which make up a majority (83%) of invasive breast cancers.
Hormonal medications are typically prescribed for five years following treatment to block the effects of estrogen on breast tissue. By hindering the action of this female hormone, these drugs can halt tumor growth. But while hormone therapies bring benefits, they also pose some risks to the heart and blood vessels.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
About the Author
Kelly Bilodeau, Former Executive Editor, Harvard Women's Health Watch
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
